Evidence map›Paper›PMID 22617151›Full record

ReviewFEBS letters2012

Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling.

Leszek Kotula

Open access · bronzeAbstract readReview
In one paragraph

Review in FEBS letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. On the existence of endocytosis driven by membrane phase separations.Biochimica et biophysica acta. Biomembranes · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Leszek KotulaNew York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA. lkotula@gmail.com
New York State Office for People With Developmental Disabilities · US

Funding

Regulation of Macropinocytosis by Hssh3bp1R01NS044968 · NINDS · NEW YORK BLOOD CENTER · PI KOTULA, LESZEK · 2003 to 2006
$1.0M
NINDS NIH HHS R01 NS044968
6 · The paper itself

Abstract

Coordination of actin cytoskeletal reorganization with growth and proliferation signals is a key cellular process that is not fully understood. PI-3 kinase is one of the central nodes for distributing growth and proliferation signals downstream from growth factor receptors to the nucleus. Although PI-3 kinase function has been associated with actin cytoskeleton remodeling, satisfactory explanations of the mechanisms mediating this regulation have been elusive. Here we propose that interaction of the Abi1 protein with the p85 regulatory subunit of PI-3 kinase represents the link between growth receptor signaling and actin cytoskeleton remodeling. This function of Abi1, which involves WAVE complex, was initially observed in macropinocytosis, and may explain the coincident dysregulation of PI-3 kinase and actin cytoskeleton in cancer.

Indexed as

Signal TransductionActinsAdaptor Proteins, Signal TransducingAnimalsCell AdhesionCell ProliferationCytoskeletal ProteinsCytoskeletonHumansModels, BiologicalNeoplasmsPhosphatidylinositol 3-KinasePinocytosisProtein BindingProtein ConformationABI1 protein, humanActinsAdaptor Proteins, Signal TransducingCytoskeletal ProteinsPhosphatidylinositol 3-Kinase

Identifiers

PMID22617151
PMCPMC4521604
OpenAlexW2077952650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.